FDA approves Quill's tissue repair device:

Executive Summary

The US FDA has approved for sale Quill Medical's barbed polydioxanone suture for closing wounds in dermal tissue. The product represents the first in a line of tissue repair devices being developed by the company, that enables sutures to "self-anchor" themselves in tissue without the surgeon having to perform a suture knot, said the Research Triangle Park, North Carolina-based firm. Quill Medical CE marked the product for sale in Europe in May.